|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size 11/10/16 American Renal Assocs Holdin… Inc 10-Q 9/30/16 61:6.1M |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 962K
2: EX-31.1 Certification -- §302 - SOA'02 HTML 25K
3: EX-31.2 Certification -- §302 - SOA'02 HTML 25K
4: EX-32.1 Certification -- §906 - SOA'02 HTML 22K
5: EX-32.2 Certification -- §906 - SOA'02 HTML 21K
12: R1 Document and Entity Information HTML 38K
13: R2 Consolidated Balance Sheets HTML 112K
14: R3 Consolidated Balance Sheets (Parenthetical) HTML 41K
15: R4 Consolidated Statements of Operations HTML 86K
16: R5 Consolidated Statements of Comprehensive Income HTML 33K
(Loss)
17: R6 Consolidated Statements of Changes in Equity HTML 86K
18: R7 Consolidated Statements of Changes in Equity HTML 21K
(Parenthetical)
19: R8 Consolidated Statements of Cash Flows HTML 133K
20: R9 Basis of Presentation and Organization HTML 42K
21: R10 Accounts Receivable HTML 25K
22: R11 Acquisitions HTML 36K
23: R12 Fair Value Measurements HTML 112K
24: R13 Accrued Expenses and Other Current Liabilities HTML 46K
25: R14 Variable Interest Entities HTML 28K
26: R15 Noncontrolling Interests Subject to Put Provisions HTML 23K
27: R16 Debt HTML 73K
28: R17 Income Taxes HTML 23K
29: R18 Stock-Based Compensation HTML 94K
30: R19 Earnings (Loss) Per Share HTML 106K
31: R20 Related Party Transactions HTML 32K
32: R21 Commitments and Contingencies HTML 26K
33: R22 Certain Legal Matters HTML 29K
34: R23 Subsequent Event HTML 20K
35: R24 Basis of Presentation and Organization (Policies) HTML 44K
36: R25 Acquisitions (Tables) HTML 28K
37: R26 Fair Value Measurements (Tables) HTML 106K
38: R27 Accrued Expenses and Other Current Liabilities HTML 46K
(Tables)
39: R28 Debt (Tables) HTML 63K
40: R29 Stock-Based Compensation (Tables) HTML 89K
41: R30 Earnings (Loss) Per Share (Tables) HTML 103K
42: R31 Basis of Presentation and Organization (Details) HTML 83K
43: R32 Accounts Receivable (Details) HTML 27K
44: R33 Acquisitions (Details) HTML 39K
45: R34 Fair Value Measurements (Details) HTML 76K
46: R35 Accrued Expenses and Other Current Liabilities HTML 35K
(Details)
47: R36 Variable Interest Entities (Details) HTML 21K
48: R37 Variable Interest Entities Loans (Details) HTML 25K
49: R38 Noncontrolling Interests Subject to Put Provisions HTML 22K
(Details)
50: R39 Debt (Details) HTML 61K
51: R40 Debt - Credit And Interest Rate Swap Agreements HTML 89K
(Details)
52: R41 Income Taxes (Details) HTML 23K
53: R42 Stock-Based Compensation (Details) HTML 122K
54: R43 Earnings (Loss) Per Share (Details) HTML 54K
55: R44 Related Party Transactions (Details) HTML 68K
56: R45 Commitments and Contingencies (Details) HTML 19K
57: R46 Certain Legal Matters (Details) HTML 25K
58: R47 Subsequent Event (Details) HTML 21K
60: XML IDEA XML File -- Filing Summary XML 104K
59: EXCEL IDEA Workbook of Financial Reports XLSX 63K
6: EX-101.INS XBRL Instance -- ara-20160930 XML 1.20M
8: EX-101.CAL XBRL Calculations -- ara-20160930_cal XML 154K
9: EX-101.DEF XBRL Definitions -- ara-20160930_def XML 424K
10: EX-101.LAB XBRL Labels -- ara-20160930_lab XML 1.13M
11: EX-101.PRE XBRL Presentations -- ara-20160930_pre XML 762K
7: EX-101.SCH XBRL Schema -- ara-20160930 XSD 116K
61: ZIP XBRL Zipped Folder -- 0001498068-16-000020-xbrl Zip 127K
| ara_Ex31-2 |
Exhibit 31.2
SECTION 302 CERTIFICATION
I, Jonathan L. Wilcox, certify that:
|
1. |
I have reviewed this Quarterly Report on Form 10-Q for the quarter ended September 30, 2016 of American Renal Associates Holdings, Inc. (the “registrant”); |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e)) and 15d-15(e)) for the registrant and have: |
|
(a) |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
(b) |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
(c) |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
(a) |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
(b) |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
Chief Financial Officer |
Date: November 10, 2016
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 11/10/16 | 8-K, SC 13G | ||
| For Period end: | 9/30/16 | |||
| List all Filings | ||||